-
Scandic Trust Group strengthens sales network with First Idea Consultant
-
Mexico's Sheinbaum to boost reporting of sexual abuse after being groped
-
Zuckerbergs put AI at heart of pledge to cure diseases
-
Crypto giant Coinbase fined in Ireland for rule breaches
-
Lawson relieved as he reveals FIA support following Mexican near-miss
-
US set for travel chaos as flights cut due to govt shutdown
-
Sabalenka and Pegula book their spots in WTA Finals last four
-
'Our brother-in-law': Arab world embraces New York's new mayor
-
France boss Deschamps would prefer to 'avoid playing' on Paris attacks anniversary
-
Pegula sweeps past Paolini to reach WTA Finals last four
-
Bolivian ex-president Anez leaves prison after sentence annuled
-
Stocks slide as investors weigh data, interest rate cuts
-
UN says 2025 to be among top three warmest years on record
-
Fleetwood and Lowry lift each other into Abu Dhabi lead
-
Fleetwod and Lowry lift each other into Abu Dhabi lead
-
New Zealand make changes after Barrett brothers' injuries as Scotland drop Van der Merwe
-
Dallas Cowboys' Marshawn Kneeland dies at 24: franchise
-
Pegula dispatches Paolini to keep WTA Finals semis bid alive
-
Dutch giants Ajax sack coach John Heitinga
-
Kirchner on trial in Argentina's 'biggest ever' corruption case
-
Amorim urges Man Utd to 'focus on future' after Ronaldo criticism
-
US judge drops criminal charges against Boeing over 737 MAX 8 crashes
-
World must face 'moral failure' of missing 1.5C: UN chief to COP30
-
UK grandmother leaves Indonesia death row to return home
-
Garcia broken nose adds to Barca defensive worries
-
Tight UK security ahead of match against Israeli club
-
Ethiopia's Afar region says attacked by Tigray forces
-
Nancy Pelosi, Democratic giant, Trump foe, first woman House speaker, to retire
-
Israel strikes Hezbollah targets in Lebanon
-
Burger strikes as South Africa restrict Pakistan to 269-9 in second ODI
-
Stocks slip as investors weigh earnings, tariffs
-
Police say 19 held after raid at Swedish start-up Stegra to be deported
-
Kante returns as France seek to clinch World Cup berth
-
Marcus Smith starts at full-back as England ring changes for Fiji
-
Kolisi 100th Test 'no distraction' for Erasmus' South Africa
-
Teetering Belgian government given more time to agree budget
-
Merz backs EU plan to protect steel sector from Chinese imports
-
New Zealand make Scotland changes after Barrett brothers' injuries
-
'Roy of the Rovers story' -- Farrell handed Ireland debut for Japan Test
-
Stones backs Man City team-mate Foden to pose England dilemma for Tuchel
-
Djokovic to face Alcaraz in ATP Finals groups
-
Facing climate 'overshoot', world heads into risky territory
-
Springbok skipper Kolisi to play 100th Test against France
-
Typhoon Kalmaegi hits Vietnam after killing 140 in Philippines
-
Bank of England leaves rate unchanged before UK budget
-
Germany recall Sane, hand El Mala debut for World Cup qualifers
-
India thump Australia to take 2-1 lead in T20 series
-
Cameroon's Biya, world's oldest president, sworn in for 8th term
-
Flick holding firm on Barca high line despite defensive woes
-
Battered US businesses eye improved China trade at Shanghai expo
US surgeons transplant pig kidney to live patient in world first
US surgeons have successfully transplanted a genetically modified pig kidney into a living patient for the first time, the hospital said Thursday, a procedure that could help address the chronic shortage of donor organs.
The four-hour operation was carried out on Saturday on a 62-year-old man suffering from end-stage kidney disease, Massachusetts General Hospital said.
"The procedure marks a major milestone in the quest to provide more readily available organs to patients," the hospital known as Mass General, or MGH, said in a statement.
Organ shortages are a chronic problem around the world and the Boston hospital said there are more than 1,400 patients on the waiting list for a kidney transplant at MGH alone.
"Our hope is that this transplant approach will offer a lifeline to millions of patients worldwide who are suffering from kidney failure," said Dr Tatsuo Kawai, a member of the team which carried out the ground-breaking operation.
The hospital said the pig kidney used for the transplant was provided by a Massachusetts biotech company called eGenesis and had been genetically-edited to remove harmful pig genes and add certain human genes.
"This represents a new frontier in medicine and demonstrates the potential of genome engineering to change the lives of millions of patients globally suffering from kidney failure," said Mike Curtis, the chief executive officer of eGenesis.
The hospital said the patient, Richard Slayman of Weymouth, Massachusetts, "is recovering well at MGH and is expected to be discharged soon."
He will be on a regimen of immunosuppressive drugs to ward off rejection of the pig kidney.
Slayman, who suffers from Type 2 diabetes and hypertension, had received a transplant of a human kidney in 2018, but it began to fail five years later and he has been on dialysis.
Slayman said he agreed to the pig kidney transplant as "not only as a way to help me, but a way to provide hope for the thousands of people who need a transplant to survive."
- 'Health equity' -
Slayman is Black and the hospital said the procedure could be of particular benefit to ethnic minorities who suffer from high rates of kidney disease.
"This health disparity has been the target of many national policy initiatives for over 30 years, with only limited success," said Slayman's nephrologist Winfred Williams.
"An abundant supply of organs resulting from this technological advance may go far to finally achieve health equity and offer the best solution to kidney failure -– a well-functioning kidney –- to all patients in need," Williams said.
The transplantation of organs from one species to another is a growing field known as xenotransplantation.
Pig kidneys had been transplanted previously into brain dead patients, but Slayman is the first living person to receive one.
Genetically modified pig hearts were transplanted recently into two patients at the University of Maryland, but both survived less than two months.
Mass General said the pigs used as organ donors were "grown in isolation under special conditions to prevent the pig from being exposed to infections that might harm the human recipient."
"These special pigs have organs of similar size and function to human organs," it said. "The genetic modifications of these pigs have also made them more compatible with humans."
Mass General said the transplant was carried out under a policy known as "compassionate use" that allows patients with "serious or life-threatening conditions" to access experimental therapies not yet been approved by the Food and Drug Administration.
S.F.Warren--AMWN